human placenta hydrolysate
Biologicalexperimental
Clinical trial activity
5 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
2
Phase 4
2
Earliest trial started Jan 1, 2013 (NCT01742013)
Timeline
Indications
Approved for
Mechanism of action
- Unspecified targetSupplementation
supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gcjbp laennec
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06493799 | Phase 3 | Jul 1, 2024 | Green Cross Corporation |
| NCT05532124 | Phase 2 | Jun 1, 2021 | Green Cross Corporation |
| NCT02675855 | Phase 4 | Jan 31, 2016 | Osiris Therapeutics |
| NCT02260609 | Phase 4 | Oct 31, 2014 | Osiris Therapeutics |
| NCT01742013 | Phase 3 | Jan 1, 2013 | Ajou University, Green Cross Corporation, Kangbuk Samsung Hospital, Symyoo |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Green Cross Corporation | For profit | 3 | 2 | 2 | 2013 |
| Osiris Therapeutics | For profit | 2 | 2 | 1 | 2014 |
| Ajou University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Kangbuk Samsung Hospital | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Symyoo | For profit | 1 | 0 | 1 | 2013 |
5 organizations
Page 1 / 1